Clinical Trial Update: Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone in premenopausal women with metastatic, est…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Faslodex (fulvestrant)
• Zoladex (goserelin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Metastatic Breast Cancer, Estrogen Receptor Positive Tumor | Phase 2 | Status: UNKNOWN